Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion

Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion

Aim. To evaluate the efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion (LAAO) in real clinical practice.Material and methods. This prospective observational study included 90 patients with nonvalvular atrial fibrillation and a high risk of ischemic stroke/s...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Pevsner, Yu. K. Rytova, I. Merkulova, E. V. Merkulov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2022-09-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation left atrial appendage occluder prevention of ischemic stroke antithrombotic therapy antiplatelet therapy anticoagulant therapy
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3353
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of left atrial appendage closure in patients with atrial fibrillation and high thromboembolic and bleeding risk
by: D. V. Pevzner, et al.
Published: (2022-09-01)

Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants
by: D. V. Pevzner, et al.
Published: (2022-09-01)

Transcatheter Left Atrial Appendage Closure
by: Gordon X. Wong, et al.
Published: (2023-05-01)

Risk factors of incomplete endothelialization after left atrial appendage occlusion in patients with atrial fibrillation
by: Jia-Min Chen, et al.
Published: (2024-06-01)

Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion
by: Stefano Branzoli, et al.
Published: (2025-05-01)

Left Atrial Appendage Occlusion: Expanding Indications and New Developments
by: Grant W. Reed, MD, MSc, et al.
Published: (2025-01-01)

Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure
by: D. V. Pevzner, et al.
Published: (2023-10-01)

THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE
by: K. V. Davtyan, et al.
Published: (2015-09-01)

Addressing Peri-Device Leaks in Next-Generation Transcatheter Left Atrial Appendage Occluders: An Open Question
by: Majid Roshanfar, et al.
Published: (2025-02-01)

A CASE OF THE LEFT ATRIUM APPENDAGE OCCLUSION, SUGGESTIONS ON THE CLINICAL FIELD DEVELOPMENT
by: K. V. Davtian, et al.
Published: (2017-10-01)

Left Atrial Appendage Occlusion: Current Landscape and Future Direction
by: Payam Safavi-Naeini, MD, MPH, et al.
Published: (2024-12-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01)

ENDOVASCULAR METHODS FOR CLOSURE OF THE LEFT ATRIAL APPENDAGE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION FOR STROKE PREVENTION
by: R. V. Guchaev, et al.
Published: (2018-05-01)

THE ENDOVASCULAR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION
by: Rami N. Al-Ayyubi, et al.
Published: (2018-12-01)

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Impact of Silent Cerebral Embolism during and after Left Atrial Appendage Occlusion on Long‐Term Cognitive Function
by: Kexin Wang, et al.
Published: (2025-02-01)

Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022-03-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

Efficacy of four different left atrial appendage closure techniques during cardiac surgery—A transesophageal echocardiography follow-up studyCentral MessagePerspective
by: Johannes Petersen, MD, et al.
Published: (2024-08-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis
by: Angelo Oliva, et al.
Published: (2024-08-01)

Pulmonary hypertension and outcomes following left atrial appendage occlusion device placement for atrial fibrillation: A population‐based analysis
by: Nadhem Abdallah, et al.
Published: (2025-04-01)

AN ANATOMICAL REVIEW OF THE HEART'S LEFT ATRIAL APPENDAGE
by: A.A. IAKIMOV, et al.
Published: (2025-07-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

Intracardiac Echocardiography to Guide Left Atrial Appendage Occlusion: An Update
by: Milos Brankovic, et al.
Published: (2025-04-01)

A new method of left atrial appendage occlusion for the prevention of thromboembolic complications in patients with atrial fibrillation during coronary artery bypass grafting
by: Yu. Yu. Vecherskiy, et al.
Published: (2020-09-01)

Associations of the left atrial epicardial fat thickness with the thrombosis prevalence and left atrial appendage flow velocity in patients with persistent non-valvular atrial fibrillation
by: E. S. Mazur, et al.
Published: (2024-05-01)

Practical aspects of antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Zh. D. Kobalava, et al.
Published: (2021-10-01)

Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019
by: K. G. Pereverzeva, et al.
Published: (2020-08-01)

Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020
by: A. S. Gerasimenko, et al.
Published: (2022-01-01)

Center-Related Variation in Hospitalization Cost for Patients Undergoing Percutaneous Left Atrial Appendage Occlusion
by: Shivaraj Patil, MD, et al.
Published: (2025-01-01)

Antithrombotic therapy in patients with atrial fibrillation hospitalised with myocardial infarction in 2016-2023: timeliness of clinical guideline adherence
by: K. G. Pereverzeva, et al.
Published: (2025-08-01)

Comparison of variants of anesthesia for left atrial appendage occlusion in patients with atrial fbrillation
by: D. V. Pevzner, et al.
Published: (2021-11-01)

THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE
by: I. S. Daaboul, et al.
Published: (2018-07-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

A case with congenital absence of the left atrial appendage
by: Kosuke Muto, et al.
Published: (2025-06-01)

Left atrial appendage occlusion and radiofrequency ablation in a patient with atrial fibrillation and dextrocardia: a case report
by: Zengfu Zhang, et al.
Published: (2025-01-01)

Robotics-assisted epicardial left atrial appendage clip exclusionCentral MessagePerspective
by: Tamim Antaki, MD, FHRS, FACS, et al.
Published: (2021-10-01)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01)

Fibrosis biomarkers as predictors of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation
by: T. P. Gizatulina, et al.
Published: (2022-08-01)